← Back to Search

Asthma patients for Asthma

N/A

Recruiting

Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial aims to investigate if asthma patients and their doctors are willing to switch inhalers for environmental reasons. Metered dose inhalers have a bigger carbon footprint than dry powder inhalers, so the study

Who is the study for?

This trial is for adults over 18 with confirmed asthma, treated at the Montreal Chest Institute or Montreal General Hospital. Participants must be on inhaled steroids and Ventolin MDI, have stable asthma without recent ER visits, and sufficient lung function to use both DPI and MDI inhalers.Check my eligibility

What is being tested?

The study aims to evaluate if asthma patients are willing to switch inhalers due to environmental concerns. It will also assess their awareness of the climate impact of different types of inhalers (MDI vs DPI) and factors influencing their choice.See study design

What are the potential side effects?

Since this is an educational intervention rather than a medical treatment, traditional side effects are not expected. However, participants may experience changes in perception regarding their health choices' environmental impact.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rotation of Ventolin MDI to Bricanyl Turbuhaler.

Secondary outcome measures

Awareness of patients regarding the climate impact of inhalers

Patients' willingness to change inhalers for environmental reasons

Proportion of patients who filled Bricanyl Rx change

+2 more

Side effects data

From 2018 Phase 4 trial • 320 Patients • NCT03068897

Gastrointestinal complaint

Drowsiness

dizziness

100%

80%

60%

40%

20%

Study treatment Arm

Metaxalone

Baclofen

Placebo

Tizanidine

Trial Design

1Treatment groups

Experimental Treatment

Group I: Asthma patientsExperimental Treatment1 Intervention

Low risk educational intervention. The consented patients will be given an information packet containing an infographic about the climate impact of inhalers, a letter explaining the option of changing inhalers (which clearly outlines that the Bricanyl Turbuhaler will not cost them more money than the Ventolin) and a pre-filled prescription for Bricanyl Turbuhaler. Also 5 selected asthma providers will be asked to fill a questionnaire on their perspectives on the climate impact of inhalers and their approach to inhaler rotation. This may also be supplemented with a phone interview

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Educational intervention

2018

Completed Phase 4

~15170

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor

447 Previous Clinical Trials

159,652 Total Patients Enrolled

4 Trials studying Asthma

732 Patients Enrolled for Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities for potential participants to enroll in this trial?

"Indeed, the information on clinicaltrials.gov states that this particular research investigation is actively enrolling subjects. The trial was first disclosed on November 7th, 2023 and last revised on March 13th, 2024. The aim is to recruit a total of 100 participants at one single site."

Answered by AI

What is the upper limit of individuals involved in this medical study?

"Affirmative. Information available on clinicaltrials.gov highlights that this research study is presently enrolling volunteers. Initially shared on November 7th, 2023, and most recently revised on March 13th, 2024, the trial aims to enroll a total of 100 participants at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient Perspective on Climate Impact of Inhalers

Nicole Ezer, MD, FRCPC, MPH 2023. "Patient Perspective on Climate Impact of Inhalers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06097507.

All > Pediatric Asthma > Asthma